Pathway Inhibitors

PQ912 View larger

PQ912

AOB36784

CAS: 1276021-65-8

 

Chemical Name: 1-(3H-Benzimidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one

More details

PQ912 was discontinued for commercial reason.

Molarity Calculation Cart®

HOW TO ORDER

$0.00

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $0.00 Total: $0.00
150 $0.00 Total: $0.00
125 $0.00 Total: $0.00
110 $0.00 Total: $0.00
15 $0.00 Total: $0.00

Data sheet

Molecular FormulaC19H20N4O2
Molecular Weight336.40
CAS Numbers1276021-65-8
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymPQ-912; PQ 912; PQ912
IUPAC/Chemical Name(S)-1-(3H-Benzimidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one
InChl KeyXHIKZWOEFZENIX-GOSISDBHSA-N
InChl CodeInChI=1S/C19H20N4O2/c1-2-9-25-15-6-3-13(4-7-15)18-11-20-19(24)23(18)14-5-8-16-17(10-14)22-12-21-16/h3-8,10,12,18H,2,9,11H2,1H3,(H,20,24)(H,21,22)/t18-/m1/s1
SMILES CodeO=C1NC[C@H](C2=CC=C(OCCC)C=C2)N1C3=CC=C4C(NC=N4)=C3
References1) Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND. Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study. Alzheimers Res Ther. 2018 Oct 12;10(1):107.

2) Pozzi C, Di Pisa F, Benvenuti M, Mangani S. The structure of the human glutaminyl cyclase-SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disorders. J Biol Inorg Chem. 2018 Dec;23(8):1219-1226.

More info

Novel Glutaminyl Cyclase (QCPT) Inhibitor, Improving Cognition in Mouse Models of Alzheimer's Disease

Customers who bought this product also bought: